Abstract Type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular disease
Warning: Semaglutide will not be prescribed to anyone with the following conditions: BMI under 27, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2, or a family history of medullary thyroid carcinoma.
Allulose is generally recognized as safe by the FDA
Mild side effects such as skin irritation and dryness are common but usually temporary
On the supply side, Lilly has turned to artificial intelligence to support sustained access